Pharmacyclics, J&J drug shown to improve leukemia survival
May 31, 2014 at 07:30 AM EDT
CHICAGO, May 31 (Reuters) - A new drug for the most common form of leukemia in adults improves survival for patients whose disease has worsened despite standard treatment, according to late-stage study findings released on Saturday.